All articles by Phalguni Deswal

Phalguni Deswal

@Phalguni_GD

Phalguni Deswal is a trainee healthcare and pharmaceutical reporter. With a background in medicine, Phalguni has experience working in the Indian healthcare sector. Phalguni is interested in metabolic drug therapies, digital health technologies, and drug development.

AstraZeneca and Cellectis partner to advance cell and gene therapies

Cellectis will receive a $25m upfront payment and up to $220m in equity investment, along with potential milestone based and royalty payments.